Per Wold-Olsen officially stepped down as GN's chair at the company's AGM | Foto: Mik Eskestad

Former GN chair says there have been no acquisition signs from Demant owner

Per Wold-Olsen left the chairperson position two weeks ago after 15 years – he now reveals there haven’t been acquisition talks behind closed doors during his time at the company.

For subscribers

JPMorgan says GN prognosis is too "conservative"

For subscribers

Owners inject EUR 100m into WS Audiology

GN board member steps down due to family health issues

For subscribers

Michael Løvbjerg, CEO and co-founder of Lizn | Foto: Lizn / Pr

New hearing company 14 years in the making – "We expect to rise to the top"

For subscribers

William Demant Invest report reveals GN Group stake

For subscribers

DNB surprised by GN's lack of backup plan
The lack of support for GN’s scrapped capital raise was to be anticipated, says a DNB analyst, meaning it would have made sense to make a plan B in advance.
For subscribers
GN's scrapped capital raise: Norges Bank voted no, William Demant Invest abstained
While the Norwegian bank contributed substantially to GN’s decision to retract a proposed DKK 7bn capital raise, William Demant Invest did not stand in the way.
For subscribers
Activist fund denies rumors – does not own GN stock
One media said Elliot Investment Management was secretly exploring a potential GN organizational split, but the fund now says it has never owned shares in the hearing company.
For subscribers
William Demant Invest has nothing to say on scrapped GN capital raise
Despite being a major shareholder of the hearing company, the investment firm maintains it ”won’t comment on any potential future suggestions” GN makes to pay off its debts.
For subscribers
New GN chair wants to find debt solution – but can't say when
GN has to find alternative solutions to solve a debt problem that shareholders will accept – and the work begins now, says newly elected Chairman Jukka Pekka Pertola.
For subscribers
Shareholders' association to GN: ”Reach out to Willian Demant Invest"
The suggestion to enter dialog with the investment company, which some think is the best bid for buying GN, was met by cheers at the annual general meeting.
For subscribers
Departing GN chair: An organizational split would be unwise
Per Wold-Olsen, who is stepping down as chairman of GN Group today, says that competitors have started copying the company’s unique business model.
For subscribers
GN retracts proposal to raise capital
In February, the hearing firm said it wanted to raise DKK 7bn on the stock exchange, but now says shareholder support was unlikely to be gained.
For subscribers
GN, Sivantos VA market shares decrease in February – Demant and Starkey gain
The US public hearing aid sales channel saw an overall drop in February volumes compared to January.
For subscribers
DNB: GN has million-dollar wiggle room in rights issue
Although the Norwegian financial services group thinks less than the announced full DKK 7bn amount would suffice, it does not believe GN leadership will change its plans to raise.
For subscribers
Analyst sees no signs of acquisition bids for GN Group
Now would be the time to come with a bid for the company – GN convenes its annual meeting with shareholders next week, where they will be asked to approve a rights issue.
For subscribers
Cochlear partners with Norwegian startup on "hearing aid" glasses
Cochlear sees hearing loss with new eyes as it partners with a Norwegian startup developing a pair of hearing eyeglasses.
For subscribers
Analysts raise expectations for Demant following annual report
Despite the new targets for the Danish hearing aid manufacturer, analysts’ projections are still in the low end of Demant’s own outlook for 2023.
For subscribers
Amplifon reports "solid revenue growth" in first months of the year
However, the world’s biggest hearing aid retailer still disappointed analysts slightly in Q4’22.
For subscribers
Audientes explains missing Q4 sales citing unexpected Indian market
During the now-concluded financial year, Audientes learned that hearing loss in India is ”more profound” than expected, and software platform upgrade to the company’s product was needed.
For subscribers
Jefferies raises GN share price target
The investment bank also raises its stock recommendation to ”buy” for the hearing firm.
For subscribers
GN’s rights issue could be less than announced
In the beginning of February, GN Group said it intended to raise DKK 7bn (USD 1bn) through a share issuance, but Deputy Chair Jukka Pekka Pertola now reports that the sum is subject to change.
For subscribers
GN, WSA recede at Veterans Affairs in January – Demant and Sonova win out
GN continues to slide at the US public hearing aid sales channel while Sonova reverses its December result.
For subscribers
Audientes expands distribution network in Nepal
A collaboration deal with Nepal-based M.B. Meditech will bring Audientes’s self-fitting hearing aid, Ven, to Nepalese customers.
For subscribers
Embattled Audientes broaches subject of company divestment
Audientes CEO Steen Thygesen opens up about the different paths forward for the company, imposing a third-quarter deadline for clearing up the hearing firm’s future.
For subscribers